Evidence map›Paper›PMID 25861985›Full record

ArticleThe Journal of biological chemistry2015

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

Robin R Shields-Cutler, Jan R Crowley, Chia S Hung, Ann E Stapleton, Courtney C Aldrich, Jonas Marschall, Jeffrey P Henderson

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04024046 (Evaluation of the Impact of the Uqora Dietary Supplement Products on Urinary Tract Infection), which is not on this map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04024046 terminatednot on this mapstarted 2019, after this paper: background citation

Evaluation of the Impact of the Uqora Dietary Supplement Products on Urinary Tract Infection (UTI) Incidence in Women With Recurring UTIs

TypeobservationalSponsorHawthorne Effect Inc.Ran2019 to 2020Enrolled360ConditionsUrinary Tract InfectionsArmsUqora, Group1, Group 2
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Effects of pH on the Pathogenicity ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. UropathogenicbioRxiv : the preprint server for biology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. ThemBio · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Robin R Shields-CutlerFrom the Division of Infectious Diseases, Department of Medicine, Center for Women's Infectious Disease Research, and.
Jan R CrowleyDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
Chia S HungFrom the Division of Infectious Diseases, Department of Medicine, Center for Women's Infectious Disease Research, and.
Ann E Stapletonthe Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington 98195.
Courtney C Aldrichthe Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, and.
Jonas MarschallFrom the Division of Infectious Diseases, Department of Medicine, the Department of Infectious Diseases, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.
Jeffrey P HendersonFrom the Division of Infectious Diseases, Department of Medicine, Center for Women's Infectious Disease Research, and jhenderson@DOM.wustl.edu.
Washington University in St. Louis · USUniversity of Minnesota · USUniversity of Washington · US

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
pan-Genome of E.coli in the bladder and gut of women with recurrent UTIP50DK064540 · NIDDK · WASHINGTON UNIVERSITY · PI HULTGREN, SCOTT J. · 2002 to 2017
$17.9M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 1985 to 2011
$16.0M
Lactobacillus probiotic for prevention of recurrent UTIR01DK088830 · NIDDK · UNIVERSITY OF WASHINGTON · PI STAPLETON, ANN E · 2011 to 2015
$3.0M
Design of Antituberculosis Agents that Target Siderophore BiosynthesisR01AI070219 · NIAID · UNIVERSITY OF MINNESOTA · PI ALDRICH, COURTNEY C · 2006 to 2013
$2.2M
EXPRESSION AND IRON-INDEPENDENT FUNCTIONS OF SIDEROPHORES IN URINARY TRACT INFECTR01DK099534 · NIDDK · WASHINGTON UNIVERSITY · PI HENDERSON, JEFFREY P · 2014 to 2018
$1.8M
Faculty Recruit for Washington University Diabetic Cardiovascular Disease CenterP30HL101263 · NHLBI · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 2009 to 2010
$1.1M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1TR000448NCRR NIH HHS P41 RR000954NCRR NIH HHS P41RR000954NHLBI NIH HHS P30 HL101263NHLBI NIH HHS P30HL101263NIAID NIH HHS R01 AI070219NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30DK056341NIDDK NIH HHS P50 DK064540NIDDK NIH HHS P50DK064540NIDDK NIH HHS R01 DK088830NIDDK NIH HHS R01 DK099534NIDDK NIH HHS R01DK099534
6 · The paper itself

Abstract

During Escherichia coli urinary tract infections, cells in the human urinary tract release the antimicrobial protein siderocalin (SCN; also known as lipocalin 2, neutrophil gelatinase-associated lipocalin/NGAL, or 24p3). SCN can interfere with E. coli iron acquisition by sequestering ferric iron complexes with enterobactin, the conserved E. coli siderophore. Here, we find that human urinary constituents can reverse this relationship, instead making enterobactin critical for overcoming SCN-mediated growth restriction. Urinary control of SCN activity exhibits wide ranging individual differences. We used these differences to identify elevated urinary pH and aryl metabolites as key biochemical host factors controlling urinary SCN activity. These aryl metabolites are well known products of intestinal microbial metabolism. Together, these results identify an innate antibacterial immune interaction that is critically dependent upon individualistic chemical features of human urine.

Indexed as

Carrier ProteinsEnterobactinEscherichia coliEscherichia coli InfectionsHumansHydrogen-Ion ConcentrationIronLipocalin-2SiderophoresUrinary Tract InfectionsUrineCarrier ProteinsEnterobactinIronLCN2 protein, humanLipocalin-2SiderophoresEscherichia coli (E. coli)host-pathogen interactioninfectious diseaseironlipocalin 2metabolomicsNGALsiderocalinsiderophoreurinary tract infection

Identifiers

PMID25861985
PMCPMC4481200
OpenAlexW1574895810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.